JP2021517459A5 - - Google Patents
Info
- Publication number
- JP2021517459A5 JP2021517459A5 JP2020548760A JP2020548760A JP2021517459A5 JP 2021517459 A5 JP2021517459 A5 JP 2021517459A5 JP 2020548760 A JP2020548760 A JP 2020548760A JP 2020548760 A JP2020548760 A JP 2020548760A JP 2021517459 A5 JP2021517459 A5 JP 2021517459A5
- Authority
- JP
- Japan
- Prior art keywords
- chain variable
- variable region
- seq
- polypeptide sequence
- heavy chain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024016283A JP2024056787A (ja) | 2018-03-13 | 2024-02-06 | 抗葉酸受容体１抗体及びその使用 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862642213P | 2018-03-13 | 2018-03-13 | |
| US62/642,213 | 2018-03-13 | ||
| PCT/US2019/021084 WO2019177854A1 (en) | 2018-03-13 | 2019-03-07 | Anti-folate receptor 1 antibodies and uses thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024016283A Division JP2024056787A (ja) | 2018-03-13 | 2024-02-06 | 抗葉酸受容体１抗体及びその使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021517459A JP2021517459A (ja) | 2021-07-26 |
| JP2021517459A5 true JP2021517459A5 (enExample) | 2022-03-14 |
| JP7433236B2 JP7433236B2 (ja) | 2024-02-19 |
Family
ID=67906883
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020548760A Active JP7433236B2 (ja) | 2018-03-13 | 2019-03-07 | 抗葉酸受容体１抗体及びその使用 |
| JP2024016283A Pending JP2024056787A (ja) | 2018-03-13 | 2024-02-06 | 抗葉酸受容体１抗体及びその使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024016283A Pending JP2024056787A (ja) | 2018-03-13 | 2024-02-06 | 抗葉酸受容体１抗体及びその使用 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US11873335B2 (enExample) |
| EP (1) | EP3765521A4 (enExample) |
| JP (2) | JP7433236B2 (enExample) |
| KR (1) | KR102808710B1 (enExample) |
| CN (1) | CN111954681B (enExample) |
| AU (1) | AU2019236091B2 (enExample) |
| BR (1) | BR112020016469A2 (enExample) |
| CA (1) | CA3091683A1 (enExample) |
| EA (1) | EA202092125A1 (enExample) |
| IL (1) | IL276949A (enExample) |
| MX (1) | MX2020009522A (enExample) |
| SG (1) | SG11202007494TA (enExample) |
| WO (1) | WO2019177854A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102275930B1 (ko) * | 2018-03-14 | 2021-07-12 | (주)알테오젠 | Folr1에 특이적으로 결합하는 항체 및 그의 용도 |
| JP7900284B2 (ja) * | 2019-12-17 | 2026-08-04 | フェインズ セラピューティクス，インコーポレーテッド | 鎖間システインが選択的にマッチングされた二重特異性抗体及びその使用 |
| TW202233684A (zh) * | 2020-11-18 | 2022-09-01 | 美商泰尼歐生物公司 | 結合於葉酸受體α之重鏈抗體 |
| WO2022217022A1 (en) * | 2021-04-10 | 2022-10-13 | Profoundbio Us Co. | Folr1 binding agents, conjugates thereof and methods of using the same |
| CN115491358B (zh) * | 2021-06-17 | 2024-09-06 | 复星凯特生物科技有限公司 | 一种靶向b7-h3和folr1双打靶点car t的制备及应用 |
| WO2025140416A1 (zh) * | 2023-12-28 | 2025-07-03 | 上海宏成药业有限公司 | 抗folr1特异性抗体的发明及应用 |
| CN118344485B (zh) * | 2024-06-18 | 2024-10-15 | 南京欧凯生物科技有限公司 | 抗叶酸及其结合蛋白复合物的单克隆抗体或其抗原结合片段、其制备方法及应用 |
Family Cites Families (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2556027C (en) * | 2004-02-12 | 2015-11-24 | Morphotek, Inc. | Monoclonal antibodies that specifically block biological activity of a tumor antigen |
| EP2172487A1 (en) | 2005-04-22 | 2010-04-07 | Morphotek Inc. | Antibodies with Immune Effector Activity that Internalize in Folate Receptor Alpha-Positive Cells |
| EP1900752A1 (en) | 2006-09-15 | 2008-03-19 | DOMPE' pha.r.ma s.p.a. | Human anti-folate receptor alpha antibodies and antibody fragments for the radioimmunotherapy of ovarian carcinoma |
| WO2008145136A1 (en) | 2007-05-30 | 2008-12-04 | Aarhus Universitet | Stat3 inactivation by inhibition of the folate receptor pathway |
| FR2929946B1 (fr) | 2008-04-11 | 2010-05-28 | Pf Medicament | Nouveaux anticorps anti-cd151 et leur utilisation pour le traitement du cancer |
| US8900588B2 (en) * | 2010-01-08 | 2014-12-02 | Les Laboratories Servier | Methods for treating breast cancer |
| CN105777907B (zh) * | 2010-02-24 | 2020-03-17 | 伊缪诺金公司 | 叶酸受体1抗体与免疫缀合物以及其用途 |
| KR20140032944A (ko) | 2010-10-20 | 2014-03-17 | 모르포테크, 인크. | 항폴레이트 수용체 알파 항체 당형태 |
| SG189957A1 (en) | 2010-11-05 | 2013-06-28 | Morphotek Inc | Folate receptor alpha as a diagnostic and prognostic marker for folate receptor alpha-expressing cancers |
| JP2014509841A (ja) | 2011-01-18 | 2014-04-24 | ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア | 癌を治療するための組成物および方法 |
| ES2661466T3 (es) | 2011-04-01 | 2018-04-02 | Immunogen, Inc. | Métodos para aumentar la eficacia de la terapia contra el cáncer con FOLR1 |
| CN107011439B (zh) | 2011-07-15 | 2020-11-10 | 卫材R&D管理有限公司 | 抗叶酸受体α抗体及其应用 |
| JP6122948B2 (ja) | 2012-05-15 | 2017-04-26 | モルフォテック， インコーポレイテッド | 胃癌の治療のための方法 |
| SG11201500938XA (en) * | 2012-08-31 | 2015-04-29 | Immunogen Inc | Diagnostic assays and kits for detection of folate receptor 1 |
| US9598489B2 (en) | 2012-10-05 | 2017-03-21 | The Trustees Of The Univeristy Of Pennsylvania | Human alpha-folate receptor chimeric antigen receptor |
| CN104884617B (zh) * | 2012-12-07 | 2019-02-19 | 协和发酵麒麟株式会社 | 抗folr1抗体 |
| US9522196B2 (en) | 2012-12-25 | 2016-12-20 | Kagoshima University | Antibody recognizing folate receptors α and β |
| US20140302037A1 (en) | 2013-03-15 | 2014-10-09 | Amgen Inc. | BISPECIFIC-Fc MOLECULES |
| EP2997044A4 (en) | 2013-05-14 | 2017-03-22 | ImmunoGen, Inc. | Anti-folr1 immunoconjugate dosing regimens |
| BR112015031950A2 (pt) | 2013-06-20 | 2017-07-25 | Morphotek Inc | métodos para tratamento de câncer de ovário |
| NZ717140A (en) * | 2013-08-30 | 2022-05-27 | Immunogen Inc | Antibodies and assays for detection of folate receptor 1 |
| JP6463744B2 (ja) | 2013-10-08 | 2019-02-06 | イミュノジェン， インコーポレイテッド | 抗ｆｏｌｒ１免疫抱合体投薬レジメン |
| EP3077522A1 (en) | 2013-12-04 | 2016-10-12 | Immunogen, Inc. | Compositions and methods for antibody production |
| KR20170020868A (ko) | 2014-06-20 | 2017-02-24 | 바이오얼라이언스 씨.브이. | 항-폴레이트 수용체 알파 (fra) 항체-약물 컨쥬게이트 및 그것의 사용 방법 |
| SG11201701565PA (en) | 2014-09-03 | 2017-03-30 | Immunogen Inc | Conjugates comprising cell-binding agents and cytotoxic agents |
| SG11201704056XA (en) * | 2014-11-20 | 2017-06-29 | Hoffmann La Roche | Combination therapy of t cell activating bispecific antigen binding molecules cd3 abd folate receptor 1 (folr1) and pd-1 axis binding antagonists |
| RS61010B1 (sr) * | 2014-11-20 | 2020-11-30 | Hoffmann La Roche | Bispecifični antigen vezujući molekuli koji aktiviraju t ćelije protiv folr1 i cd3 |
| WO2016126608A1 (en) | 2015-02-02 | 2016-08-11 | Novartis Ag | Car-expressing cells against multiple tumor antigens and uses thereof |
| CA2983126A1 (en) | 2015-04-17 | 2016-10-20 | Morphotek, Inc. | Methods for treating lung cancer |
| CN122075735A (zh) | 2015-09-17 | 2026-05-26 | 伊缪诺金公司 | 包含抗folr1免疫缀合物的治疗组合 |
| US20190233512A1 (en) | 2016-10-12 | 2019-08-01 | Sutro Biopharma, Inc. | Anti-folate receptor antibodies, compositions comprising anti-folate receptor antibodies and methods of making and using anti-folate receptor antibodies |
| US10822410B2 (en) | 2016-11-23 | 2020-11-03 | Eisai R&D Management Co., Ltd. | Anti-folate receptor alpha antibodies and uses thereof |
| BR112019023909A8 (pt) | 2017-05-16 | 2023-04-11 | Immunogen Inc | Uso de um imunoconjugado que se liga a folr1, e, uso de um imunoconjugado que se liga a folr1 e pembrolizumab |
-
2019
- 2019-03-07 EP EP19767635.6A patent/EP3765521A4/en active Pending
- 2019-03-07 MX MX2020009522A patent/MX2020009522A/es unknown
- 2019-03-07 AU AU2019236091A patent/AU2019236091B2/en active Active
- 2019-03-07 KR KR1020207028499A patent/KR102808710B1/ko active Active
- 2019-03-07 JP JP2020548760A patent/JP7433236B2/ja active Active
- 2019-03-07 SG SG11202007494TA patent/SG11202007494TA/en unknown
- 2019-03-07 BR BR112020016469-0A patent/BR112020016469A2/pt not_active IP Right Cessation
- 2019-03-07 CN CN201980019246.4A patent/CN111954681B/zh active Active
- 2019-03-07 EA EA202092125A patent/EA202092125A1/ru unknown
- 2019-03-07 CA CA3091683A patent/CA3091683A1/en active Pending
- 2019-03-07 WO PCT/US2019/021084 patent/WO2019177854A1/en not_active Ceased
- 2019-03-07 US US15/733,541 patent/US11873335B2/en active Active
-
2020
- 2020-08-26 IL IL276949A patent/IL276949A/en unknown
-
2024
- 2024-02-06 JP JP2024016283A patent/JP2024056787A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021516057A5 (enExample) | ||
| JP2021514664A5 (enExample) | ||
| JP2021526022A5 (enExample) | ||
| JP7209464B2 (ja) | ヒトインターロイキン－２に対する免疫刺激性モノクローナル抗体 | |
| JP2022509930A (ja) | 抗ｃｄ７３抗体、その抗原結合フラグメントおよびそれらの使用 | |
| JP2020536488A5 (enExample) | ||
| JP2024531409A5 (enExample) | ||
| JP2021528047A5 (enExample) | ||
| RU2019118359A (ru) | Антитело к cd73 человека | |
| JP2021500916A5 (enExample) | ||
| IL310938A (en) | Anti-CCR8 antibodies and their uses | |
| JP2022534135A5 (enExample) | ||
| JP2022533538A5 (enExample) | ||
| RU2015142815A (ru) | Лечение рака с использованием антител, связывающихся с поверхностным grp78 | |
| JP7533897B2 (ja) | 融合タンパク質およびその使用 | |
| CN112513094A (zh) | 结合人her2的抗体、其制备方法和用途 | |
| JP2017149720A5 (enExample) | ||
| JP2021512652A5 (enExample) | ||
| JP2020522281A5 (enExample) | ||
| JP2020522280A5 (enExample) | ||
| JP2024538148A5 (enExample) | ||
| JP2020515277A5 (enExample) | ||
| CN109867723B (zh) | 抗人il6单克隆抗体及其制备方法和用途 | |
| CN114805570B (zh) | 一种抗人ace2单克隆抗体及其应用 | |
| JP2024516621A5 (enExample) |